应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
DXCM 德康医疗
交易中 05-02 15:19:44 EDT
126.32
+0.44
+0.35%
最高
127.88
最低
124.61
成交量
125.38万
今开
127.03
昨收
125.88
日振幅
2.60%
总市值
502.33亿
流通市值
495.00亿
总股本
3.98亿
成交额
1.57亿
换手率
0.32%
流通股本
3.92亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
德康医疗2024财年第一财季实现净利润1.46亿美元,同比增加200.41%
自选股智能写手 · 04-30
德康医疗2024财年第一财季实现净利润1.46亿美元,同比增加200.41%
嗡嗡声--美国股票走势-雪佛龙、英特尔、Alphabet
Reuters · 04-27
嗡嗡声--美国股票走势-雪佛龙、英特尔、Alphabet
BUZZ-Dexcom 因 2024 年收入预期下调而下跌
Reuters · 04-26
BUZZ-Dexcom 因 2024 年收入预期下调而下跌
德康医疗盘中异动 早盘股价大跌5.10%报130.97美元
自选股智能写手 · 04-26
德康医疗盘中异动 早盘股价大跌5.10%报130.97美元
加拿大投资银行集团:维持DexCom(DXCM.US)评级,由买入调整至买入评级, 目标价由144.00美元调整至145.00美元。
智通财经 · 04-26
加拿大投资银行集团:维持DexCom(DXCM.US)评级,由买入调整至买入评级, 目标价由144.00美元调整至145.00美元。
血糖监测仪需求强劲,Dexcom 盈利超出预期
Reuters · 04-26
血糖监测仪需求强劲,Dexcom 盈利超出预期
Dexcom Inc 预计每股收益27美分 - 财报前瞻
Reuters · 04-24
Dexcom Inc 预计每股收益27美分 - 财报前瞻
德康医疗盘中异动 早盘股价大涨5.00%
自选股智能写手 · 03-25
德康医疗盘中异动 早盘股价大涨5.00%
德康医疗盘中异动 急速上涨5.86%
自选股智能写手 · 03-06
德康医疗盘中异动 急速上涨5.86%
BUZZ-美国食品及药物管理局批准使用首款非处方连续血糖监测仪后,DexCom 的业绩上升
Reuters · 03-06
BUZZ-美国食品及药物管理局批准使用首款非处方连续血糖监测仪后,DexCom 的业绩上升
美国 FDA 批准使用首款非处方连续血糖监测仪
Reuters · 03-06
美国 FDA 批准使用首款非处方连续血糖监测仪
BUZZ-Tandem Diabetes 宣布可转换债务交易后下跌
Reuters · 03-05
BUZZ-Tandem Diabetes 宣布可转换债务交易后下跌
德康医疗盘中异动 大幅上涨5.00%报120.82美元
自选股智能写手 · 03-02
德康医疗盘中异动 大幅上涨5.00%报120.82美元
德康医疗2023财年实现净利润5.42亿美元,同比增加58.94%
自选股智能写手 · 02-12
德康医疗2023财年实现净利润5.42亿美元,同比增加58.94%
德康医疗盘中异动 股价大跌5.00%报120.70美元
自选股智能写手 · 02-10
德康医疗盘中异动 股价大跌5.00%报120.70美元
葡萄糖监测仪需求强劲,Dexcom 盈利超出预期
Reuters · 02-09
葡萄糖监测仪需求强劲,Dexcom 盈利超出预期
Dexcom Inc 预计每股收益43美分 - 财报前瞻
Reuters · 02-07
Dexcom Inc 预计每股收益43美分 - 财报前瞻
美国研究综述-美国电话电报公司、伦诺克斯国际公司、万事达卡
Reuters · 02-01
美国研究综述-美国电话电报公司、伦诺克斯国际公司、万事达卡
德康医疗盘中异动 股价大跌5.02%报120.15美元
自选股智能写手 · 01-26
德康医疗盘中异动 股价大跌5.02%报120.15美元
美国研究综述-美国水务公司、家得宝、Lowe's
Reuters · 01-22
美国研究综述-美国水务公司、家得宝、Lowe's
加载更多
公司概况
公司名称:
德康医疗
所属市场:
NASDAQ
上市日期:
--
主营业务:
德康医疗公司是一家注册于特拉华州的公司。该公司是一家医疗器械公司,主要专注于设计、开发和商业化连续血糖监测(CGM)系统,用于管理世界各地的患者、护理人员和临床医生的糖尿病。
发行价格:
--
{"stockData":{"symbol":"DXCM","market":"US","secType":"STK","nameCN":"德康医疗","latestPrice":126.315,"timestamp":1714677580029,"preClose":125.88,"halted":0,"volume":1253782,"delay":0,"floatShares":391879203,"shares":397683837,"eps":1.53676,"marketStatus":"交易中","marketStatusCode":2,"change":0.435,"latestTime":"05-02 15:19:44 EDT","open":127.03,"high":127.88,"low":124.61,"amount":157470994.55978,"amplitude":0.025977,"askPrice":126.34,"askSize":76,"bidPrice":126.29,"bidSize":229,"shortable":3,"etf":0,"ttmEps":1.53676,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1714680000000},"adr":0,"listingDate":1113451200000,"adjPreClose":125.88,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":126.83,"preClose":125.88,"latestTime":"09:29 EDT","volume":1189,"amount":150756.89483499998,"timestamp":1714656599999},"postHourTrading":{"tag":"盘后","latestPrice":125.5,"preClose":125.88,"latestTime":"19:50 EDT","volume":114629,"amount":14400530.1111,"timestamp":1714607435487},"volumeRatio":0.309169},"requestUrl":"/m/hq/s/DXCM/","defaultTab":"news","newsList":[{"id":"2431874818","title":"德康医疗2024财年第一财季实现净利润1.46亿美元,同比增加200.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431874818","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431874818?lang=zh_cn&edition=full","pubTime":"2024-04-30 00:27","pubTimestamp":1714408046,"startTime":"0","endTime":"0","summary":"3月31日,德康医疗公布财报,公告显示公司2024财年第一财季净利润为1.46亿美元,同比增加200.41%;其中营业收入为9.21亿美元,同比增加24.12%,每股基本收益为0.38美元。从资产负债表来看,德康医疗总负债42.35亿美元,其中短期债务20.70百万美元,资产负债比为1.54,流动比率为2.90。机构评级:截至2024年3月31日,当前有23家机构对德康医疗目标价做出预测,其中目标均价为152.77美元,其中最低目标价为132.00美元,最高目标价为170.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404300027378b62d5e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404300027378b62d5e7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430444781","title":"嗡嗡声--美国股票走势-雪佛龙、英特尔、Alphabet","url":"https://stock-news.laohu8.com/highlight/detail?id=2430444781","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2430444781?lang=zh_cn&edition=full","pubTime":"2024-04-27 02:04","pubTimestamp":1714154695,"startTime":"0","endTime":"0","summary":" * 个股异动的 Eikon 搜索字符串:[STXBZ] * The Day Ahead 新闻通讯: * The Morning News Call时事通讯: 4月26日 - 周五华尔街主要股指上扬,原因是 Alphabet 公司强劲的季度业绩推动其市值超过 2 万亿美元,多数大型成长股上涨,而通胀数据与预期持平也平息了加息的不安情绪。美东时间13:37,道琼斯工业平均指数 上涨0.65%,报38,331.51点。标准普尔500指数 上涨1.29%,报5,113.68点;纳斯达克综合指数 上涨2.31%,报15,972.848点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2430956204","title":"BUZZ-Dexcom 因 2024 年收入预期下调而下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2430956204","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2430956204?lang=zh_cn&edition=full","pubTime":"2024-04-26 23:24","pubTimestamp":1714145099,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 4月26日 - ** 医疗设备制造商Dexcom 股价下跌6.4%,至129.15美元** DXCM 2024 年收入预测为 42 亿至 43.5 亿美元,低于华尔街预期的 43.2 亿美元中点。** 公司周四在 (link) 发布第一季度每股收益为 32 美分,高于分析师平均预期的 27 美分 - LSEG ** 年初至今股价下跌 4.1%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2430639203","title":"德康医疗盘中异动 早盘股价大跌5.10%报130.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430639203","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430639203?lang=zh_cn&edition=full","pubTime":"2024-04-26 21:40","pubTimestamp":1714138857,"startTime":"0","endTime":"0","summary":"北京时间2024年04月26日21时40分,德康医疗股票出现异动,股价大幅下挫5.10%。截至发稿,该股报130.97美元/股,成交量94.4195万股,换手率0.24%,振幅5.58%。最近的财报数据显示,该股实现营业收入36.22亿美元,净利润5.42亿美元,每股收益1.40美元,毛利22.81亿美元,市盈率85.36倍。德康医疗股票所在的医疗器械行业中,整体跌幅为0.24%。该信息摘要如下:加拿大投资银行集团:维持DexCom评级,由买入调整至买入评级, 目标价由144.00美元调整至145.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042621405787e84340&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042621405787e84340&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430727427","title":"加拿大投资银行集团:维持DexCom(DXCM.US)评级,由买入调整至买入评级, 目标价由144.00美元调整至145.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2430727427","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430727427?lang=zh_cn&edition=full","pubTime":"2024-04-26 20:56","pubTimestamp":1714136177,"startTime":"0","endTime":"0","summary":"加拿大投资银行集团:维持DexCom(DXCM.US)评级,由买入调整至买入评级, 目标价由144.00美元调整至145.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042620562487b3c6fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042620562487b3c6fd&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430342263","title":"血糖监测仪需求强劲,Dexcom 盈利超出预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2430342263","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2430342263?lang=zh_cn&edition=full","pubTime":"2024-04-26 06:29","pubTimestamp":1714084181,"startTime":"0","endTime":"0","summary":"LSEG的数据显示,在截至3月31日的三个月里,Dexcom的总收入增长了24%,达到9.21亿美元,超过了分析师平均预期的9.0924亿美元。这家总部位于加利福尼亚州的公司最新推出的连续血糖监测系统 G7 于 2022 年在美国获得批准。Dexcom公布的调整后利润为每股32美分,而分析师预计为每股27美分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2429400591","title":"Dexcom Inc 预计每股收益27美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2429400591","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2429400591?lang=zh_cn&edition=full","pubTime":"2024-04-24 05:18","pubTimestamp":1713907092,"startTime":"0","endTime":"0","summary":" * Dexcom Inc 将于4月25日发布截至2024年3月31日的季度财报,预计该公司的季度收入将有所增长。* 根据LSEG的数据,21位分析师的平均预期显示,这家总部位于加利福尼亚州圣迭戈的公司的营收将从去年同期的7.415亿美元增至9.09238亿美元,增幅为22.6%。* LSEG分析师对Dexcom公司的平均预期为每股收益27美分。* 华尔街对 Dexcom Inc 的 12 个月目标价中位数为 150.00 美元,高于其上次收盘价 131.52 美元。4月23日 - 上一季度业绩。除非另有说明,所有数字均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2422543210","title":"德康医疗盘中异动 早盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422543210","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422543210?lang=zh_cn&edition=full","pubTime":"2024-03-25 22:01","pubTimestamp":1711375308,"startTime":"0","endTime":"0","summary":"北京时间2024年03月25日22时01分,德康医疗股票出现异动,股价大幅上涨5.00%。截至发稿,该股报139.84美元/股,成交量66.7224万股,换手率0.17%,振幅4.83%。机构评级方面,在所有25家参与评级的机构中,88%的券商给予买入建议,12%的券商给予持有建议,无券商给予卖出建议。德康医疗股票所在的医疗器械行业中,整体涨幅为0.38%。德康医疗公司简介:德康医疗公司为糖尿病患者设计并商业化连续血糖监测系统。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240325220148791cae5a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240325220148791cae5a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417297322","title":"德康医疗盘中异动 急速上涨5.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2417297322","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417297322?lang=zh_cn&edition=full","pubTime":"2024-03-06 22:30","pubTimestamp":1709735443,"startTime":"0","endTime":"0","summary":"北京时间2024年03月06日22时30分,德康医疗股票出现波动,股价大幅拉升5.86%。截至发稿,该股报128.92美元/股,成交量6.0053万股,换手率0.02%,振幅0.10%。机构评级方面,在所有24家参与评级的机构中,88%的券商给予买入建议,12%的券商给予持有建议,无券商给予卖出建议。德康医疗股票所在的医疗器械行业中,整体跌幅为1.09%。德康医疗公司简介:德康医疗公司为糖尿病患者设计并商业化连续血糖监测系统。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403062230437a4a1da0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403062230437a4a1da0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417260858","title":"BUZZ-美国食品及药物管理局批准使用首款非处方连续血糖监测仪后,DexCom 的业绩上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2417260858","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2417260858?lang=zh_cn&edition=full","pubTime":"2024-03-06 20:33","pubTimestamp":1709728433,"startTime":"0","endTime":"0","summary":"** 周二晚些时候,美国食品和药物管理局批准 使用 DXCM 的设备,使其成为首个可在柜台购买的连续血糖监测仪 ** 这种可佩戴 15 天的传感器名为 Stelo,适用于不使用胰岛素的 2 型糖尿病患者。** Stelo 的非处方药可认证性令人吃惊,因为 DXCM 公开将该产品定位为需要处方的现金支付选择\"--经纪公司 BTIG ** DXCM 将美国市场的规模定为大约 2500 万人,目前 CGM 的渗透率不到 5%,主要由雅培公司的 Libre 葡萄糖监测设备主导。** 截至上一交易日收盘,股价年累计下跌约 2","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2417203314","title":"美国 FDA 批准使用首款非处方连续血糖监测仪","url":"https://stock-news.laohu8.com/highlight/detail?id=2417203314","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2417203314?lang=zh_cn&edition=full","pubTime":"2024-03-06 05:29","pubTimestamp":1709674144,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 路透社3月5日 - 美国食品和药物管理局周二表示,该机构已批准使用Dexcom公司的 设备,使其成为首个在柜台销售的连续血糖监测仪。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2417443525","title":"BUZZ-Tandem Diabetes 宣布可转换债务交易后下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2417443525","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2417443525?lang=zh_cn&edition=full","pubTime":"2024-03-05 23:46","pubTimestamp":1709653592,"startTime":"0","endTime":"0","summary":" 3月5日 - ** Tandem Diabetes Care 股价周二早盘下跌9.4%至28.21美元,原因是该医疗设备公司寻求融资为部分债务再融资。** CBs 是一种证券,在满足某些条件的情况下可以转换成股票或现金** 随着本交易日的走势,TNDM的股价今年以来下跌了4.5%,但在过去三个月里上涨了33%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2416362967","title":"德康医疗盘中异动 大幅上涨5.00%报120.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2416362967","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416362967?lang=zh_cn&edition=full","pubTime":"2024-03-02 01:06","pubTimestamp":1709312816,"startTime":"0","endTime":"0","summary":"北京时间2024年03月02日01时06分,德康医疗股票出现异动,股价急速拉升5.00%。截至发稿,该股报120.82美元/股,成交量184.482万股,换手率0.48%,振幅6.10%。最近的财报数据显示,该股实现营业收入36.22亿美元,净利润5.42亿美元,每股收益1.40美元,毛利22.81亿美元,市盈率92.89倍。机构评级方面,在所有24家参与评级的机构中,88%的券商给予买入建议,12%的券商给予持有建议,无券商给予卖出建议。德康医疗股票所在的医疗器械行业中,整体涨幅为0.90%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240302010656861da9b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240302010656861da9b6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2410885171","title":"德康医疗2023财年实现净利润5.42亿美元,同比增加58.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2410885171","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2410885171?lang=zh_cn&edition=full","pubTime":"2024-02-12 00:27","pubTimestamp":1707668862,"startTime":"0","endTime":"0","summary":"12月31日,德康医疗公布财报,公告显示公司2023财年净利润为5.42亿美元,同比增加58.94%;其中营业收入为36.22亿美元,同比增加24.47%,每股基本收益为1.40美元。从资产负债表来看,德康医疗总负债41.96亿美元,其中短期债务21.10百万美元,资产负债比为1.50,流动比率为2.85。机构评级:截至2023年12月31日,当前有21家机构对德康医疗目标价做出预测,其中目标均价为147.51美元,其中最低目标价为122.00美元,最高目标价为170.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021200274781836f73&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021200274781836f73&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2410806614","title":"德康医疗盘中异动 股价大跌5.00%报120.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2410806614","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2410806614?lang=zh_cn&edition=full","pubTime":"2024-02-10 01:59","pubTimestamp":1707501576,"startTime":"0","endTime":"0","summary":"北京时间2024年02月10日01时59分,德康医疗股票出现异动,股价快速下跌5.00%。截至发稿,该股报120.70美元/股,成交量334.91万股,换手率0.87%,振幅3.56%。最近的财报数据显示,该股实现营业收入36.22亿美元,净利润5.42亿美元,每股收益1.40美元,毛利22.89亿美元,市盈率92.93倍。德康医疗股票所在的医疗器械行业中,整体跌幅为0.36%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240210015936861d4e10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240210015936861d4e10&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2410778899","title":"葡萄糖监测仪需求强劲,Dexcom 盈利超出预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2410778899","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2410778899?lang=zh_cn&edition=full","pubTime":"2024-02-09 06:07","pubTimestamp":1707430073,"startTime":"0","endTime":"0","summary":" 路透2月8日 - 血糖监测仪制造商Dexcom 周四公布的第四季度财报超过了分析师的预期,这主要得益于对其连续血糖监测 系统的强劲需求。除去其他项目,Dexcom第四季度每股盈利50美分,高于分析师平均预期的43美分。尽管如此,Dexcom 仍只是重申了 1 月份给出的 2024 年 41.5-43.5 亿美元的预测。2023 年底,由于投资者担心 GLP-1 药物对 CGM 市场的影响,Dexcom 的股价受到短暂打击。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2409239028","title":"Dexcom Inc 预计每股收益43美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2409239028","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2409239028?lang=zh_cn&edition=full","pubTime":"2024-02-07 05:19","pubTimestamp":1707254352,"startTime":"0","endTime":"0","summary":" * Dexcom公司 将于2月8日公布截至2023年12月31日的财报,预计该公司的季度收入将有所增长。* 根据LSEG的数据,20位分析师的平均预期显示,这家总部位于加利福尼亚州圣迭戈的公司的营收将从去年同期的8.152亿美元增长24.6%,达到10.16亿美元。 * LSEG 分析师对 Dexcom 公司的平均预期为每股收益 43 美分。* 华尔街对 Dexcom Inc 的 12 个月目标价中位数为 145.00 美元,高于其上次收盘价 121.23 美元。2月6日 - 上一季度业绩。除非另有说明,所有数字均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2408550592","title":"美国研究综述-美国电话电报公司、伦诺克斯国际公司、万事达卡","url":"https://stock-news.laohu8.com/highlight/detail?id=2408550592","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2408550592?lang=zh_cn&edition=full","pubTime":"2024-02-01 17:08","pubTimestamp":1706778485,"startTime":"0","endTime":"0","summary":" 路透2月1日 - 华尔街证券分析师周四调整了对几家美国上市公司的评级和目标价,其中包括美国电话电报公司、伦诺克斯国际公司和万事达卡公司。* 8X8 Inc :巴克莱将目标价从2.50美元上调至3美元 * AMD Inc :Northland Capital上调其评级至 \"跑赢大盘\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2406933792","title":"德康医疗盘中异动 股价大跌5.02%报120.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2406933792","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2406933792?lang=zh_cn&edition=full","pubTime":"2024-01-26 23:34","pubTimestamp":1706283296,"startTime":"0","endTime":"0","summary":"北京时间2024年01月26日23时34分,德康医疗股票出现波动,股价快速下挫5.02%。截至发稿,该股报120.15美元/股,成交量110.551万股,换手率0.29%,振幅4.80%。最近的财报数据显示,该股实现营业收入9.75亿美元,净利润1.21亿美元,每股收益0.31美元,毛利6.22亿美元,市盈率132.25倍。机构评级方面,在所有24家参与评级的机构中,88%的券商给予买入建议,12%的券商给予持有建议,无券商给予卖出建议。德康医疗股票所在的医疗器械行业中,整体涨幅为0.03%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240126233456790c80c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240126233456790c80c8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2405945157","title":"美国研究综述-美国水务公司、家得宝、Lowe's","url":"https://stock-news.laohu8.com/highlight/detail?id=2405945157","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2405945157?lang=zh_cn&edition=full","pubTime":"2024-01-22 15:28","pubTimestamp":1705908512,"startTime":"0","endTime":"0","summary":" 路透1月22日 - 华尔街证券分析师周一调整了对几家美国上市公司的评级和目标价,其中包括美国水务公司、家得宝和劳氏公司。要闻 * 美国水务公司 :摩根大通将目标价从139美元下调至128美元 * Home Depot Inc :奥本海默将其评级从 \"跑赢大盘 \"下调至 \"表现良好\"。* Lowe's Companies Inc :奥本海默将其评级从 \"跑赢大盘 \"下调至 \"表现良好\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.dexcom.com","stockEarnings":[{"period":"1week","weight":-0.087},{"period":"1month","weight":-0.0874},{"period":"3month","weight":0.0268},{"period":"6month","weight":0.2916},{"period":"1year","weight":0.0657},{"period":"ytd","weight":0.0144}],"compareEarnings":[{"period":"1week","weight":-0.01},{"period":"1month","weight":-0.0418},{"period":"3month","weight":0.0228},{"period":"6month","weight":0.1511},{"period":"1year","weight":0.2179},{"period":"ytd","weight":0.0527}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"德康医疗公司是一家注册于特拉华州的公司。该公司是一家医疗器械公司,主要专注于设计、开发和商业化连续血糖监测(CGM)系统,用于管理世界各地的患者、护理人员和临床医生的糖尿病。","yearOnYearQuotes":[{"month":1,"riseRate":0.684211,"avgChangeRate":0.062776},{"month":2,"riseRate":0.368421,"avgChangeRate":0.004747},{"month":3,"riseRate":0.631579,"avgChangeRate":0.029425},{"month":4,"riseRate":0.578947,"avgChangeRate":0.0598},{"month":5,"riseRate":0.55,"avgChangeRate":0.023921},{"month":6,"riseRate":0.789474,"avgChangeRate":0.066013},{"month":7,"riseRate":0.473684,"avgChangeRate":0.008051},{"month":8,"riseRate":0.789474,"avgChangeRate":0.094391},{"month":9,"riseRate":0.315789,"avgChangeRate":-0.038957},{"month":10,"riseRate":0.368421,"avgChangeRate":-0.03061},{"month":11,"riseRate":0.526316,"avgChangeRate":0.025918},{"month":12,"riseRate":0.578947,"avgChangeRate":0.048654}],"exchange":"NASDAQ","name":"德康医疗","nameEN":"DexCom"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"德康医疗(DXCM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供德康医疗(DXCM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"德康医疗,DXCM,德康医疗股票,德康医疗股票老虎,德康医疗股票老虎国际,德康医疗行情,德康医疗股票行情,德康医疗股价,德康医疗股市,德康医疗股票价格,德康医疗股票交易,德康医疗股票购买,德康医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"德康医疗(DXCM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供德康医疗(DXCM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}